TRACE. Real-Life Clinical Use of Tralokinumab Observational Cohort Study of Patients With Atopic Dermatitis Prescribed Tralokinumab
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: LEO PHARMA A/S
- Execution start: 09/11/2022
- End of execution: 30/12/2024
- PI: RICARDO RUIZ VILLAVERDE
